Fed. Circ. Rejects Pharma Co. Refiling Suit To Reset Deadline
Ascendis Pharma missed its window to invoke a mandatory stay in California federal court based on parallel U.S. International Trade Commission proceedings, and its attempt to reset the patent litigation doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article